Literature DB >> 23598498

A comparative chemical-biological evaluation of titanium(IV) complexes with a salan or cyclopentadienyl ligand.

Julia Schur1, Cesar M Manna, Anthony Deally, Reinhard W Köster, Matthias Tacke, Edit Y Tshuva, Ingo Ott.   

Abstract

Titanium(IV) complexes with a salan or cyclopentadienyl ligand showed different biological behaviour concerning binding to biomolecules, cellular accumulation and intracellular distribution. Binding efficacy as well as trafficking on the cellular level are crucial parameters for their biological effects.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23598498     DOI： 10.1039/c3cc38604j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  11 in total

1.  Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.

Authors:  Isabel de la Cueva-Alique; Laura Muñoz-Moreno; Yosra Benabdelouahab; Benelita T Elie; Mohammed Amin El Amrani; Marta E G Mosquera; María Contel; Ana M Bajo; Tomás Cuenca; Eva Royo
Journal:  J Inorg Biochem       Date:  2015-12-09       Impact factor: 4.155

Review 2.  A ubiquitous metal, difficult to track: towards an understanding of the regulation of titanium(iv) in humans.

Authors:  Sergio A Loza-Rosas; Manoj Saxena; Yamixa Delgado; Kavita Gaur; Mallesh Pandrala; Arthur D Tinoco
Journal:  Metallomics       Date:  2017-04-19       Impact factor: 4.526

3.  Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.

Authors:  Sergio A Loza-Rosas; Alexandra M Vázquez-Salgado; Kennett I Rivero; Lenny J Negrón; Yamixa Delgado; Josué A Benjamín-Rivera; Angel L Vázquez-Maldonado; Timothy B Parks; Charlene Munet-Colón; Arthur D Tinoco
Journal:  Inorg Chem       Date:  2017-06-23       Impact factor: 5.165

4.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

5.  Unusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and Toxicity.

Authors:  Arthur D Tinoco; Manoj Saxena; Shweta Sharma; Nicholas Noinaj; Yamixa Delgado; Ernesto P Quiñones González; Steven E Conklin; Nicole Zambrana; Sergio A Loza-Rosas; Timothy B Parks
Journal:  J Am Chem Soc       Date:  2016-04-26       Impact factor: 15.419

6.  The elements of life and medicines.

Authors:  Prinessa Chellan; Peter J Sadler
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2015-03-13       Impact factor: 4.226

7.  Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug.

Authors:  Maya Miller; Anna Mellul; Maya Braun; Dana Sherill-Rofe; Emiliano Cohen; Zohar Shpilt; Irene Unterman; Ori Braitbard; Jacob Hochman; Edit Y Tshuva; Yuval Tabach
Journal:  iScience       Date:  2020-06-12

8.  Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs.

Authors:  Lauren Fernandez-Vega; Valeria A Ruiz Silva; Tania M Domínguez-González; Sebastián Claudio-Betancourt; Rafael E Toro-Maldonado; Luisa C Capre Maso; Karina Sanabria Ortiz; Jean A Pérez-Verdejo; Janeishly Román González; Grecia T Rosado-Fraticelli; Fabiola Pagán Meléndez; Fabiola M Betancourt Santiago; Daniel A Rivera-Rivera; Carlos Martínez Navarro; Andrea C Bruno Chardón; Axel O Vera; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2020-01-26

9.  Triazol-substituted titanocenes by strain-driven 1,3-dipolar cycloadditions.

Authors:  Andreas Gansäuer; Andreas Okkel; Lukas Schwach; Laura Wagner; Anja Selig; Aram Prokop
Journal:  Beilstein J Org Chem       Date:  2014-07-17       Impact factor: 2.883

10.  In vitro combinations of inert phenolato Ti(iv) complexes with clinically employed anticancer chemotherapy: synergy with oxaliplatin on colon cells.

Authors:  N Ganot; E Y Tshuva
Journal:  RSC Adv       Date:  2018-02-06       Impact factor: 4.036
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.